Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders

Authors:

Abstract
Introduction: Current drugs for the treatment of psychiatric or neurodegenerative disorders have limitations. Psychotherapeutic drugs such as typical and atypical antipsychotics, tricyclic antidepr...

This publication has 137 references indexed in Scilit: